Florian Lordick

Florian Lordick: Niche2 data presented by Myriam Chalabi

Florian Lordick, Professor of Medicine at University of Leipzig and Director of the Comprehensive Cancer Center Central Germany, shared a post on LinkedIn:

”ESMO24 exciting colorectal proffered paper session Niche2 data presented by Myriam Chalabi.

Unpredented 100% DFS with neoadjuvant Nivolumab-Ipilimumab for locally advanced colon cancer. Prediction of pCR still difficult. ctDNA may help.”

Florian Lordick

Source: Florian Lordick/LinkedIn

cancer Colon cancer Comprehensive Cancer Center Central Germany ESMO24 Florian Lordick ipilimumab Myriam Chalabi nivolumab OncoDaily Oncology University of Leipzig